文献速递慢性肾脏病肾血管病与高血压

高危患者肾脏长度与心血管及肾脏风险的关系

Relation between Kidney Length and Cardiovascular and Renal Risk in High-Risk Patients.
PubMed 文献 · Clin J Am Soc Nephrol · 2017-05-09

在SMART队列10251例有临床动脉疾病或血管危险因素的患者中,肾脏长度与体表面积和eGFR强相关;中位随访6.3年,肾脏长度第三分位(11.7-16.1 cm)患者心血管死亡和心血管事件风险更高,且不依赖eGFR,第一分位(7.8-10.8 cm)未见风险升高。

要点

  • 肾脏长度与体表面积和eGFR强相关。
  • 肾脏长度第三分位(11.7-16.1 cm)患者心血管死亡风险升高(HR 1.33)。
  • 肾脏长度第三分位患者心血管事件风险升高(HR 1.28),不依赖eGFR。

核心结论

  • 在高危患者中,肾脏长度较大与心血管事件和死亡风险升高相关,且不依赖eGFR。
  • 肾脏长度可能作为临床标志物进一步识别高心血管风险患者。

研究设计与样本

  • 研究人群为SMART队列中1996至2014年纳入的10251例有临床明显动脉疾病或血管危险因素的患者。
  • 采用线性回归探索肾脏长度的患者特征,采用Cox回归分析肾脏长度与心血管事件、全因死亡及ESRD的关系。
  • 肾脏长度按三分位分析,以第二分位为参照。

主要发现

  • 肾脏长度与体表面积强相关(每增加0.1 m2,长度增加2.04 mm;95%CI 1.95-2.13)。
  • 肾脏长度与eGFR强相关(每增加10 ml/min per 1.73 m2,长度增加1.62 mm;95%CI 1.52-1.73)。
  • 中位随访6.3年,1317例发生心血管事件(其中心肌梗死711例、卒中369例、血管性死亡735例),1462例全因死亡,52例发生ESRD。
  • 肾脏长度第三分位(11.7-16.1 cm)患者心血管死亡风险升高(HR 1.33;95%CI 1.05-1.67),心血管事件风险升高(HR 1.28;95%CI 1.09-1.50),不依赖eGFR。
  • 肾脏长度第一分位(7.8-10.8 cm)患者未见心血管不良事件风险升高。

临床怎么用

  • 在常规腹部超声测量肾脏长度时,可关注长度较大(如第三分位11.7-16.1 cm)的高危患者,其心血管风险可能升高。
  • 肾脏长度可作为附加信息辅助心血管风险分层,但需结合eGFR等指标综合评估。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND AND OBJECTIVES: Kidney length is often measured during routine abdominal ultrasonography and may be of use to identify patients at high vascular and renal risk. We aimed to explore patient characteristics related to kidney length, from which reference values were derived, and evaluate the relationship between kidney length and the risk of cardiovascular events and ESRD in high-risk patients. DESIGN, SETTING, PARTICIPANTS, & MEASUREMENTS: The study population consisted of 10,251 patients with clinical manifest arterial disease or vascular risk factors included in the Second Manifestations of ARTerial disease (SMART) Study cohort between 1996 and 2014. Linear regression was used to explore patient characteristics of kidney length. The relationship between kidney length and cardiovascular events (myocardial infarction, stroke, and cardiovascular mortality), all-cause mortality, and ESRD was analyzed using Cox regression. Kidney length was analyzed in tertiles, using the second tertile as the reference category. RESULTS: Kidney length was strongly correlated with body surface area (2.04 mm; 95% confidence interval [95% CI], 1.95 to 2.13 per 0.1 m2 increase) and eGFR (1.62 mm; 95% CI, 1.52 to 1.73 per 10 ml/min per 1.73 m2 increase). During the median follow-up of 6.3 years, 1317 patients experienced a cardiovascular event, including 711 myocardial infarctions, 369 strokes, and 735 vascular cause deaths. A total of 1462 patients died of any cause and 52 patients developed ESRD. Irrespective of eGFR, patients in the third tertile of kidney length (11.7-16.1 cm) were at higher risk of cardiovascular mortality (hazard ratio, 1.33; 95% CI, 1.05 to 1.67) and cardiovascular events (hazard ratio, 1.28; 95% CI, 1.09 to 1.50). Patients in the first tertile of kidney length (7.8-10.8 cm) were not at higher risk of cardiovascular adverse events. CONCLUSIONS: Large kidney length is related to higher risk of cardiovascular events and mortality in high-risk patients, irrespective of eGFR. Kidney length may serve as a clinical marker to further identify patients at high cardiovascular risk.

来源:Clin J Am Soc Nephrol,查看原文。版权归原作者所有。

引用

  1. van der Sande NGC, Visseren FLJ, van der Graaf Y, et al. Relation between Kidney Length and Cardiovascular and Renal Risk in High-Risk Patients. Clin J Am Soc Nephrol. 2017. PMID: 28487344. doi:10.2215/CJN.08990816

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。